NASDAQ, ORCH - Orchid Cellmark Inc.
Orchid Cellmark is a leading international provider of identity DNA testing services for the forensic, immigration and family relationships markets. The company has accredited laboratories in the U.S. and the U.K. and its primary customers include police forces and other government entities. The company's corporate headquarters is in Princeton, N.J. Orchid Cellmark is well known for its high quality and service levels and has undergone significant change over the last three years. The company continues to grow both organically and via acquisitions. In 2009 the company completed the build out of its second facility in the northern part of the U.K. as a result of the company's significant U.K. forensic growth. In the U.S. it recently completed another acquisition that became accretive within less than one year of its acquisition. Orchid Cellmark is well positioned to capitalize on the changing market dynamics of the U.K. market and the expected emerging growth of the U.S. market as the U.S. DNA forensic testing market expands to include all arrestee testing and the use of DNA testing for property crime and other high volume/high value applications. ...
Read SEC Filing on NASDAQ.com »